After 44 years of fighting the "war on cancer," we’re still losing and the lack of research funding is one of the key reasons, writes Cynthia Reinhart-King. Read more
A diverse collection of novel agents are on the horizon that could further improve the long-term outcomes experienced by patients with follicular lymphoma, according to John Leonard, M.D. Read more
Patients diagnosed with chronic lymphocytic leukemia who are treated with new targeted agents may have a normal life span, according to John Allan, M.D. Read more
Leandro Cerchietti, M.D., has identified a potential new strategy for the treatment of aggressive diffuse large B-cell lymphomas (DLBCL) called double and triple hit lymphomas. Read more
The lab of Lorraine Gudas, Ph.D., has identified a gene that may provide a new, super specific target for drugs that could stop kidney cancer progression in its tracks. Read more